| « Previous month | Next month » |
Manufacturers of custom synthetic oligonucleotides (oligos) could see competition from new entrants into the sector, according to a survey which finds that customers are not entirely happy with their suppliers.
Stringent rules to protect the high quality, and high market value compared to other vegetable fats, of European olive oil are now in place. But reliant on honest labelling, the market could remain vulnerable. A new study from the Finnish food watchdog is encouraging but shows oil suppliers need to tighten up their labelling skills.
The European Commission has reported on its progress in building up Europe's competitiveness in the biotechnology and concludes that while positive steps have been taken, there is still much to be done, particularly with regard to intellectual property rights.
A new system to detect salmonella within 24 hours is being developed by scientists in Spain. The breakthrough is significant as the bacteria is one of the most common causes of food poisoning, and the new process could help food manufacturers limit any potential outbreak.
The Chilled Food Association (CFA) has launched a guide to help chilled food manufacturers meet their legislative commitments and commercial requirements regarding controls on veterinary residues, just days after the Soil Association challenged residue contamination in eggs.
Filtration specialist Millipore has reported impressive growth in sales in the first quarter of 2004, suggesting that the strength of the biopharmaceutical industry - Millipore's primary customer - may be on the up.
A new screening approach which can identify a new drug mechanism of action without the need for an appropriate molecular target has been used to suppress genetic mutation. The discovery raises new hopes of identifying potential new drugs, harnessing this new drug-discovery approach to other diseases.
IntelliChem, a developer of electronic laboratory notebooks (ELN) for the drug discovery and development industry, has launched a new ELN platform that can be used right across any pharmaceutical or biotechnology company.
Scientific bodies in the accession companies to the European Union have expressed concern about the overall standard of science across the EU at a meeting in Slovenia.
Germany's Merck KGaA has completed the $1.65 billion (€1.32bn) sale of its laboratory distribution business, VWR International, to US investment firm Clayton, Dubilier & Rice.
An electronic nose could sniff out considerable savings for food manufacturers as researchers use the latest technology for the early detection of 'undesirable off-odours and microbial contaminants' in dairy and bakery products.
UK fine chemical company Ultrafine is to be acquired by Sigma-Aldrich of the US in a move aimed at strengthening the latter's offerings for the pharmaceutical and biotech industry.
Membrane Extraction Technology has launched a new version of its METcell - a chemically-resistant high pressure stirred cell used in development laboratories in the pharmaceutical and chemical industry - that can cope with more corrosive compounds.
General Electric has completed its €8.1 billion acquisition of UK healthcare company Amersham, promising to create a new company that will 'change the face of healthcare,' according to GE chief executive Jeffrey Immelt.
A scientist has claimed that nanotechnology - devoted to engineering tiny machines with applications as diverse as drug delivery, electronics and materials science - could pose a health hazard and should be investigated further before being widely adopted, reports Phil Taylor.
Distek has developed a new product in its range of devices for testing how well pharmaceutical tablets dissolve that does not need a water bath. The benefit? A reduction in maintenance, faster throughput and less system vibration and noise than bath-based systems.
Beckman Coulter, the leading manufacturer of instrument systems and automated laboratory processes, has launched two new laboratory automation workstations which promise to set new standards in accuracy and precision of assays.
Biotrove has reported promising data from a study of its Living Chip microfluidic technology used to generate genotyping data from human genomic samples. Their high-density array chip promises to hike the throughout rate for this type of experiment, writes Wai Lang Chu.
A panel of scientists in the US has developed a method to assess the safety of common supplements based on available lab and animal data, and suggests that this process could be used by regulators to get round the lack of human clinical evidence on many natural products.
| « Previous month | Next month » |